LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Colon Cancer Screen 59 Tissue Microarray - LS-SCOCA59

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SCOCA59
Product Name: Colon Cancer Screen 59
Description: Colon adenocarcinoma (grade II) with stage/grade
Format: FFPE
Category: Human Tumor
QA/QC: H&E reviewed; IHC validated with a positive control antibody
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: Yes
Core Diameter: 1.5 mm
Core Thickness: 5 µm
Cases: 21
Cores: 63
Slides Per Set: 1

LS-SCOCA59 Tissue Microarray Map

Slide Number 1
LABEL
 123456789
AColColColColColColColColCol
BColColColColColColColColCol
CColColColColColColColColCol
DColColColColColColColColCol
EColColColColColColColColCol
FColColColColColColColColCol
GColColColColColColColColSmI
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Colon (Col); Colon, Fibrous tissue and smooth muscle (Col); Colon, Mucosa (Col); Colon, Smooth muscle (Col); Small intestine, Mucosa (SmI);

LS-SCOCA59 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis TypeTumor Grade
1A1HumanM37 yColon (Col)AdenocarcinomaMalignantGrade II
1A2HumanM37 yColon (Col)AdenocarcinomaMalignantGrade II
1A3HumanM37 yColon (Col)AdenocarcinomaMalignantGrade II
1A4HumanF52 yColon (Col)AdenocarcinomaMalignantGrade I
1A5HumanF52 yColon (Col)AdenocarcinomaMalignantGrade I
1A6HumanF52 yColon (Col)AdenocarcinomaMalignantGrade I
1A7HumanM61 yColon (Col)AdenocarcinomaMalignantGrade II
1A8HumanM61 yColon (Col)AdenocarcinomaMalignantGrade I
1A9HumanM61 yColon (Col)AdenocarcinomaMalignantGrade II
1B1HumanF48 yColon (Col)AdenocarcinomaMalignantGrade I
1B2HumanF48 yColon (Col)AdenocarcinomaMalignantGrade I
1B3HumanF48 yColon (Col)AdenocarcinomaMalignantGrade I
1B4HumanM82 yColon (Col)AdenocarcinomaMalignantGrade I
1B5HumanM82 yColon (Col)AdenocarcinomaMalignantGrade I
1B6HumanM82 yColon (Col)AdenocarcinomaMalignantGrade I
1B7HumanM75 yColon (Col)AdenocarcinomaMalignantGrade II
1B8HumanM75 yColon (Col)AdenocarcinomaMalignantGrade I
1B9HumanM75 yColon (Col)AdenocarcinomaMalignantGrade I
1C1HumanF43 yColon (Col)AdenocarcinomaMalignantGrade I
1C2HumanF43 yColon (Col)AdenocarcinomaMalignantGrade I
1C3HumanF43 yColon (Col)AdenocarcinomaMalignantGrade I
1C4HumanM55 yColon (Col)AdenocarcinomaMalignantGrade I
1C5HumanM55 yColon (Col)AdenocarcinomaMalignantGrade I
1C6HumanM55 yColon (Col)AdenocarcinomaMalignantGrade II
1C7HumanF51 yColon (Col)AdenocarcinomaMalignantGrade I
1C8HumanF51 yColon (Col)AdenocarcinomaMalignantGrade I
1C9HumanF51 yColon (Col)AdenocarcinomaMalignantGrade I
1D1HumanM60 yColon (Col)AdenocarcinomaMalignantGrade I
1D2HumanM60 yColon (Col)AdenocarcinomaMalignantGrade I
1D3HumanM60 yColon (Col)AdenocarcinomaMalignantGrade I
1D4HumanF17 yColon (Col)AdenocarcinomaMalignantGrade II
1D5HumanF17 yColon (Col)AdenocarcinomaMalignantGrade II
1D6HumanF17 yColon (Col)AdenocarcinomaMalignantGrade II
1D7HumanM62 yColon (Col)AdenocarcinomaMalignantGrade I
1D8HumanM62 yColon (Col)AdenocarcinomaMalignantGrade I
1D9HumanM62 yColon (Col)AdenocarcinomaMalignantGrade II
1E1HumanM54 yColon (Col)AdenocarcinomaMalignantGrade II
1E2HumanM54 yColon (Col)AdenocarcinomaMalignantGrade II
1E3HumanM54 yColon (Col)AdenocarcinomaMalignantGrade II
1E4HumanM66 yColon (Col)AdenocarcinomaMalignantGrade II
1E5HumanM66 yColon (Col)AdenocarcinomaMalignantGrade II
1E6HumanM66 yColon (Col)AdenocarcinomaMalignantGrade II
1E7HumanF41 yColon (Col)AdenocarcinomaMalignantGrade I
1E8HumanF41 yColon (Col)AdenocarcinomaMalignantGrade I
1E9HumanF41 yColon (Col)AdenocarcinomaMalignantGrade I
1F1HumanF63 yColon (Col)AdenocarcinomaMalignantGrade II
1F2HumanF63 yColon (Col)AdenocarcinomaMalignantGrade II
1F3HumanF63 yColon (Col)AdenocarcinomaMalignantGrade II
1F4HumanM68 yColon (Col)AdenocarcinomaMalignantGrade II
1F5HumanM68 yColon (Col)AdenocarcinomaMalignantGrade II
1F6HumanM68 yColon, Smooth muscle (Col)Inflammation, ChronicInflammatory 
1F7HumanM46 yColon (Col)AdenocarcinomaMalignantGrade II
1F8HumanM46 yColon (Col)AdenocarcinomaMalignantGrade II
1F9HumanM46 yColon (Col)AdenocarcinomaMalignantGrade II
1G1HumanF68 yColon (Col)AdenocarcinomaMalignantGrade I
1G2HumanF68 yColon (Col)AdenocarcinomaMalignantGrade I
1G3HumanF68 yColon (Col)AdenocarcinomaMalignantGrade I
1G4HumanM68 yColon (Col)AdenocarcinomaMalignantGrade I
1G5HumanM68 yColon (Col)AdenocarcinomaMalignantGrade I
1G6HumanM68 yColon (Col)AdenocarcinomaMalignantGrade II
1G7HumanF52 yColon, Fibrous tissue and smooth muscle (Col)NormalBenign non-neoplastic 
1G8HumanM61 yColon, Mucosa (Col)NormalBenign non-neoplastic 
1G9HumanM50 ySmall intestine, Mucosa (SmI)NormalBenign non-neoplastic 
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved